JEFFREY ADELGLASS, M.D., F.A.C.S.
CLINICAL RESEARCH STUDIES
Dallas | ft. worth TEXAS
currently enrolling subjects for
PAID CLINICAL RESEARCH participation
The Chikungunya (CHIKV) virus is a mosquito-borne tropical disease that is currently spreading throughout the southeastern U.S. states from Brazil. The initial onset of illness usually occurs 4-8 days after being bitten by an infected mosquito. Chikungunya causes muscle pain, joint swelling, headache, nausea, rash and fatigue. This joint pain can be debilitating, lasting for days or even years in some cases.
Issues with vision, neurological, and heart complications have been reported with Chikungunya virus infections, as well as gastrointestinal problems. While serious complications are not common, Chikungunya can contribute to the cause of death in older individuals with other illnesses. Most who are infected are able to recover fully from the infection, but ongoing joint pain can be a problem for some. It is believed that once an individual recovers, they may be immune from future infections. At this time, there is currently no FDA-approved vaccine for Chikungunya; Research Your Health may soon be participating in a study to determine whether an investigational vaccine will prove to be effective against it.
Are You Interested in Participating in a Chikungunya Vaccine Study?
A Chikungunya Vaccine study will be starting soon for Adults at Research Your Health in Plano, Texas. All study-related visits, tests and care, along with the study vaccine will be provided at no cost to you. Participants who qualify to take part in the study will receive compensation, depending on the number of completed visits) for time and travel.
1. Complete the interest form to the right.
2. When the study is about to start, our screening department will call you to pre-screen and schedule you to visit our center.
Call 972-746-2222 Now to Schedule